Nevertheless, in the present case, upadacitinib induced the rapid resolution of a severe RA flare-up occurring during anti-PD-1 ICI therapy for advanced lung squamous cell carcinoma. This evidence concerns the gene PDCD1 and squamous cell lung carcinoma.